연구성과로 돌아가기

2023 연구자 정보 (954 / 1135)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 ⓘ 교신저자 여부 ⓘ Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Lee, Weon-Young
(Lee, WY) ⓘ 		Chung Ang Univ, Coll Med, Dept Prevent Med, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 46.7] Korea Seroprevalence Study of Monitoring of SARS-COV-2 Antibody Retention and Transmission (K-SEROSMART): findings from national representative sample ⓘ SCIE ⓘ 46.7 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH ⓘ solee5301@gmail.com;dhkims@hallym.ac.kr; ⓘ
Nam, Do-Hyun
(Nam, D) ⓘ 		교신저자 Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Neurosurg, 81 Irwon Ro, Seoul 06351, South Korea
Samsung Med Ctr, Inst Refractory Canc Res, Seoul, South Korea
Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Grad Sch Hlth Sci & Technol, Seoul, South Korea
Samsung Med Ctr, 81 Irwon Ro, Seoul 06351, South Korea
Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Samsung Med Ctr,Dept Neurosurg,Sch Med, Dept Hlth Sci & Technol,Inst Refractory Canc Res,, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 46.7] A multicenter, phase II trial of GC1118, a novel anti-EGFR antibody, for recurrent glioblastoma patients with EGFR amplification
[JCR상위 14.0] The semaphorin 3A/neuropilin-1 pathway promotes clonogenic growth of glioblastoma via activation of TGF-β signaling
[JCR상위 1.2] Tissue factor is a critical regulator of radiation therapy-induced glioblastoma remodeling ⓘ 		SCIE ⓘ 1.2 ONCOLOGY
MEDICINE, RESEARCH & EXPERIMENTAL
CELL BIOLOGY;ONCOLOGY ⓘ 		nsnam@ssku.edu;sehoon.lee@samsung.com;
nsnam@skku.edu;leej7@ccf.org;
leej7@ccf.org; ⓘ
Nam, Hae-Sung
(Nam, HS) ⓘ 		Chungnam Natl Univ, Coll Med, Dept Prevent Med, Daejeon, South Korea ⓘ
ⓘ 		0000-0003-0911-4576
Nam, Hae-Sung ⓘ 		[JCR상위 46.7] Korea Seroprevalence Study of Monitoring of SARS-COV-2 Antibody Retention and Transmission (K-SEROSMART): findings from national representative sample ⓘ SCIE ⓘ 46.7 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH ⓘ solee5301@gmail.com;dhkims@hallym.ac.kr; ⓘ
Nam, Jeonghyun
(Nam, J) ⓘ 		Natl Inst Infect Dis, Ctr Vaccine Res, Div Vaccine Clin Res, Cheongju, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 46.7] Korea Seroprevalence Study of Monitoring of SARS-COV-2 Antibody Retention and Transmission (K-SEROSMART): findings from national representative sample ⓘ SCIE ⓘ 46.7 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH ⓘ solee5301@gmail.com;dhkims@hallym.ac.kr; ⓘ
Noh, Eunbi
(Noh, E) ⓘ 		Korea Inst Radiol & Med Sci, Natl Radiat Emergency Med Ctr, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 46.7] Korea Seroprevalence Study of Monitoring of SARS-COV-2 Antibody Retention and Transmission (K-SEROSMART): findings from national representative sample ⓘ SCIE ⓘ 46.7 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH ⓘ solee5301@gmail.com;dhkims@hallym.ac.kr; ⓘ
Oh, Chang-Mo
(Oh, CM) ⓘ 		Kyung Hee Univ, Sch Med, Dept Prevent Med, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 46.7] Korea Seroprevalence Study of Monitoring of SARS-COV-2 Antibody Retention and Transmission (K-SEROSMART): findings from national representative sample ⓘ SCIE ⓘ 46.7 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH ⓘ solee5301@gmail.com;dhkims@hallym.ac.kr; ⓘ
Oh, Sangcheol
(Oh, S) ⓘ 		MAPO Gu Publ Hlth Ctr, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 46.7] Korea Seroprevalence Study of Monitoring of SARS-COV-2 Antibody Retention and Transmission (K-SEROSMART): findings from national representative sample ⓘ SCIE ⓘ 46.7 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH ⓘ solee5301@gmail.com;dhkims@hallym.ac.kr; ⓘ
Oh, Sungsoo
(Oh, S) ⓘ 		Yonsei Univ, Wonju Coll Med, Dept Occupat & Environm Med, Wonju, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 46.7] Korea Seroprevalence Study of Monitoring of SARS-COV-2 Antibody Retention and Transmission (K-SEROSMART): findings from national representative sample ⓘ SCIE ⓘ 46.7 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH ⓘ solee5301@gmail.com;dhkims@hallym.ac.kr; ⓘ
Park, Chul-Kee
(Park, CK) ⓘ 		Seoul Natl Univ Hosp, Coll Med, Dept Neurosurg, Seoul, South Korea
Seoul Natl Univ, Coll Med, Dept Neurosurg, Seoul, South Korea
Seoul Natl Univ Hosp, Seoul, South Korea ⓘ 		J-5499-2012
Park, Chul-Kee ⓘ 		0000-0002-2350-9876
Park, Chul-Kee ⓘ 		[JCR상위 46.7] A multicenter, phase II trial of GC1118, a novel anti-EGFR antibody, for recurrent glioblastoma patients with EGFR amplification
[JCR상위 4.5] Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma ⓘ 		SCIE ⓘ 4.5 ONCOLOGY
GENETICS & HEREDITY ⓘ 		nsnam@ssku.edu;sehoon.lee@samsung.com;
nsproper@naver.com;benedict.yoon@samsung.com;jgwang@ust.hk; ⓘ
Park, Ki-Soo
(Park, KS) ⓘ 		Gyeongsang Natl Univ, Inst Hlth Sci, Coll Med, Dept Prevent Med, Jinju, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 46.7] Korea Seroprevalence Study of Monitoring of SARS-COV-2 Antibody Retention and Transmission (K-SEROSMART): findings from national representative sample ⓘ SCIE ⓘ 46.7 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH ⓘ solee5301@gmail.com;dhkims@hallym.ac.kr; ⓘ
Park, No Yai
(Park, NY) ⓘ 		Inje Univ, Grad Sch Publ Hlth, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 46.7] Korea Seroprevalence Study of Monitoring of SARS-COV-2 Antibody Retention and Transmission (K-SEROSMART): findings from national representative sample ⓘ SCIE ⓘ 46.7 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH ⓘ solee5301@gmail.com;dhkims@hallym.ac.kr; ⓘ
Park, Soon-Woo
(Park, SW) ⓘ 		Daegu Catholic Univ, Sch Med, Dept Prevent Med, Gyongsan, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 46.7] Korea Seroprevalence Study of Monitoring of SARS-COV-2 Antibody Retention and Transmission (K-SEROSMART): findings from national representative sample ⓘ SCIE ⓘ 46.7 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH ⓘ solee5301@gmail.com;dhkims@hallym.ac.kr; ⓘ
Ryu, Soo Ho
(Ryu, SH) ⓘ 		제1저자 Kyungpook Natl Univ, Pharmaceut Sci Res Inst, Coll Pharm, Daegu, South Korea
Kyungpook Natl Univ, Res Inst Pharmaceut Sci, Coll Pharm, Dept Pharm, Daegu, South Korea
Kyungpook Natl Univ, Res Inst Pharmaceut Sci, Coll Pharm, 80 Daehak Ro, Daegu 41566, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 46.7] Jujuboside B post-treatment attenuates PM2.5-induced lung injury in mice
[JCR상위 70.2] Jujuboside B Inhibited High Mobility Group Box Protein 1-Mediated Severe Inflammatory Responses in Human Endothelial Cells and Mice
[JCR상위 50.7] Hepatoprotective functions of jujuboside B ⓘ 		SCIE ⓘ 46.7 ENVIRONMENTAL SCIENCES;PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
CHEMISTRY, MEDICINAL;FOOD SCIENCE & TECHNOLOGY;NUTRITION & DIETETICS
CHEMISTRY, MEDICINAL;PHARMACOLOGY & PHARMACY ⓘ 		baejs@knu.ac.kr; ⓘ
Ryu, Soyeon
(Ryu, S) ⓘ 		Chosun Univ, Coll Med, Dept Prevent Med, Gwangju, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 46.7] Korea Seroprevalence Study of Monitoring of SARS-COV-2 Antibody Retention and Transmission (K-SEROSMART): findings from national representative sample ⓘ SCIE ⓘ 46.7 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH ⓘ solee5301@gmail.com;dhkims@hallym.ac.kr; ⓘ
Seol, Roma
(Seol, R) ⓘ 		Inje Univ, Coll Med, Dept Prevent Med, Busan, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 46.7] Korea Seroprevalence Study of Monitoring of SARS-COV-2 Antibody Retention and Transmission (K-SEROSMART): findings from national representative sample ⓘ SCIE ⓘ 46.7 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH ⓘ solee5301@gmail.com;dhkims@hallym.ac.kr; ⓘ
페이지 이동: